<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0032">
 <label>32</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Abo-Ashour</surname>
    <given-names>MF</given-names>
   </name>, 
   <name name-style="western">
    <surname>Eldehna</surname>
    <given-names>WM</given-names>
   </name>, 
   <name name-style="western">
    <surname>Nocentini</surname>
    <given-names>A</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: synthesis, in vitro biological evaluation and in silico insights</article-title>. 
  <source>Eur J Med Chem</source>
  <year>2019</year>;
  <volume>184</volume>:
  <fpage>111768</fpage>.
  <pub-id pub-id-type="pmid">31629164</pub-id>
 </mixed-citation>
</ref>
